Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump

The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales…

More information at SECLaw.com Read the Full Press Release

---

Have a securities law question? Call New York Securities Lawyers at 212-509-6544.